MSB 3.21% $1.13 mesoblast limited

MSB AGM - confidence restored, page-23

  1. 1,609 Posts.
    lightbulb Created with Sketch. 1691
    Doesn't answer my question - why should we suddenly believe that THIS TIME they have the FDA's number and have answered all their questions to the point the FDA will approve it within the next 6-9 months?

    I don't see anything different, save for the new data, which had never been discussed by MSB before, but is now suddenly being sold by SI as a game changer. Sounds kinda stinky to me.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.